Home NDC 51144-050 ADCETRIS
Product NDC 51144-050
11-digit product format 511440050
Labeler code 51144
Product ID 51144-050_a695c1a2-3acc-468b-a829-c8761dc041f6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name brentuximab vedotin
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler SEAGEN INC.
Application BLA125388
Marketing category BLA
Marketing start 2011-08-25
Substance BRENTUXIMAB VEDOTIN
Active strength 50 mg/10.5mL
Pharmacologic classes CD30-directed Antibody Interactions [MoA], CD30-directed Immunoconjugate [EPC], Immunoconjugates [CS], Microtubule Inhibition [PE]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base ADCETRIS
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BRENTUXIMAB VEDOTIN 50 mg/10.5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7XL5ISS668 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1147323 Internal RxNorm lookup 1147327 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51144-050-01 ADCETRIS 1 in 1 BOX INJECTION, POWDER, LYOPHILIZED, 1 38 51144-050-01 ADCETRIS 10.5 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 10.5 38
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Brentuximab Vedotin ACTIVE INGREDIENT 7XL5ISS668 ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] 15 Brentuximab Vedotin ACTIVE MOIETY 7XL5ISS668 ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] 15 Citric Acid Monohydrate INACTIVE INGREDIENT 2968PHW8QP ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] 15 Polysorbate 80 INACTIVE INGREDIENT 6OZP39ZG8H ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] 15 Trehalose Dihydrate INACTIVE INGREDIENT 7YIN7J07X4 ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] 15 Trisodium Citrate Dihydrate INACTIVE INGREDIENT B22547B95K ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] 15
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51144-050 ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEAGEN INC.] 36 Current NDC, Legacy NDC, 2 package rows 20250221_3904f8dd-1aef-3490-e48f-bd55f32ed67f.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125388 Adcetris brentuximab vedotin 351(a) Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 51144-050-01 51144005001 1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01) / 10.5 mL in 1 VIAL, SINGLE-DOSE 2011-08-25 0000-00-00 No No Current